Skip to content
Review

Physical Stimuli–Assisted Intracellular Access and Endosomal Escape of Nanoparticles for Application in Nanomedicine: A Review

Aug 2026 · ACS Applied Nano Materials · 0 citations · 221 references

TL;DR

How photothermal, magnetothermal, piezoelectric, sonodynamic, and acoustically responsive nanomaterials modulate nanoparticle–cell interactions through membrane perturbation, uptake enhancement, vesicle destabilization, altered intracellular trafficking, and nonclassical transport pathways is discussed.

Abstract

Endosomal sequestration remains a major barrier to the intracellular delivery of nanotherapeutics/nanomedicine, prompting the development of physically responsive nanomaterials activated by light, magnetic fields, and ultrasound. These external stimuli are widely proposed to induce endosomal escape through localized heating, mechanical perturbation, cavitation, membrane permeabilization, or reactive oxygen species generation. However, growing quantitative evidence suggests that in many systems only a limited fraction of internalized nanoparticles undergoes bona fide cytosolic release following stimulation, often accounting for less than 10–15% of the total intracellular population. This Review critically examines the mechanistic basis of physical stimuli–assisted endosomal escape and distinguishes true cytosolic delivery from broader stimulation-induced intracellular effects. We discuss how photothermal, magnetothermal, piezoelectric, sonodynamic, and acoustically responsive nanomaterials modulate nanoparticle–cell interactions through membrane perturbation, uptake enhancement, vesicle destabilization, altered intracellular trafficking, and nonclassical transport pathways. Importantly, we discuss why substantial therapeutic responses can still arise despite modest endosomal release, owing to enhanced intracellular accumulation and improved local bioavailability. Finally, we outline emerging strategies for quantitative mechanistic evaluation and propose a more realistic framework in which physical stimulation is viewed not solely as an endosomolytic trigger, but as a broader regulator of intracellular access relevant to next-generation nanomedicine design.

View source

Similar papers

Open access Sep 2026

Physical mechanisms of nanoparticle intracellular release through membrane pore nucleation and expansion

Successful intracellular delivery requires a nanocarrier to adhere to the cell membrane, be wrapped and internalized and finally released into the cytoplasm before it is degraded. While the initial steps have been intensively studied, the intracellular release of a nanocarrier has received comparatively less attention...

Massimiliano Paesani, I. Ilie · 0 citations
Review Open access Oct 2026

Organelle-Targeted Nanocarriers for Cancer Therapy: Design Principles, Intracellular Trafficking, and Translational Barriers in Precision Drug Delivery

Abstract The clinical translation of cancer nanomedicine remains constrained by inefficient intracellular delivery, poor subcellular specificity, and limited tumor accumulation, highlighting the need for more precise drug delivery strategies. Organelle-targeted nanocarriers have emerged as a promising platform for enha...

Han-Gen Zhang, Jia Guo, Xin-Miao Wang et al. · 0 citations
#gene editing Open access Sep 2026

Lipid nanoparticle induced model endosomal membrane disruption

This study uses giant unilamellar vesicles mimicking the endosomal membrane to directly visualize the interaction and membrane disruptions caused by two model LNPs constituted by two different ionizable lipids, establishing a cell-free platform for dissecting individual sub-steps of endosomal escape.

Shreya Pramanik, Aishwarya Vasudevan, Zheng-Hua Liang et al. · 0 citations
Review Open access Sep 2026

Designing nature's nanocarriers: advances and challenges in functionalizing bacterial extracellular vesicles.

This review examines luminal targeting strategies (secretion pathway-mediated loading, lipoprotein anchoring, and membrane scaffold fusions), surface display platforms, and genetic yield-enhancement mechanisms to advance bEVs toward clinically viable, programmable delivery systems.

Varun Kumar, Hannah C. Zierden, Sara Molinari · 0 citations
Review Open access Aug 2026

Engineered extracellular vesicles: pharmacological barriers, engineering strategies, and translational opportunities

Extracellular vesicle (EV) therapeutics are progressing from broad proof-of-concept studies toward product-specific engineering and clinically defined applications. Native EVs offer biological membrane functions and the capacity to transport diverse molecular cargoes, but their therapeutic performance is limited by low...

Jiao Xu, Zhi Li, Da Liu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.